BioWorld MedTech

May 9, 2012

NewCo on the Block: MID secures bridge financing, prepares for first-in-man trial

The market for percutaneous catheter-based heart procedures such as transcatheter aortic valve replacement (TAVR) has been developing at a rapid pace, but vascular access and closure devices have not been able to keep up. Read More

St. Jude Medical gains FDA approval for Assura portfolio

Report from Europe: Truer Medical earns CE mark for range of medical devices

Washington roundup: Upton: White House will see FDA user fee bill by July 4

Financings roundup: Select Medical commences $365M placement of notes

Agreements/contracts: Luna Innovations, Philips to build new robotic device

HIT roundup: Telit cellular module to connect CardioNet MCOT

Restructuring roundup: HearUSA's amended plan of liquidation accepted

Product Briefs

People in the News

MDD's Oncology Extra

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...